-
β-Pseudouridine: An Assay-First RNA Guide
2026-08-31
β-Pseudouridine is a powerful probe for connecting RNA modification chemistry with structure and translational fidelity. This assay-first guide interprets recent self-amplifying RNA vaccine findings while clarifying what the free nucleoside can—and cannot—demonstrate experimentally.
-
Honokiol Workflows for NF-κB and Cancer Assays
2026-08-30
Honokiol supports mechanism-focused studies of NF-κB signaling, oxidative stress, viability, and tumor angiogenesis. This workflow shows how to separate growth arrest from cell killing while controlling solvent, timing, and assay-specific artifacts.
-
Ionomycin free acid: Calcium Signaling Workflows
2026-08-29
Ionomycin free acid provides a direct, controllable way to raise intracellular calcium for live-cell signaling, FAK proteolysis studies, and oocyte activation workflows. This guide translates the FAISL–FAK findings into practical assay designs while separating established evidence from testable calcium-perturbation hypotheses.
-
Oridonin, MAPK/NF-κB, and Bone Protection
2026-08-29
The 2023 reference study shows that oridonin can counter thioacetamide-associated bone injury through a dual mechanism: suppressing osteoclast differentiation through MAPK/NF-κB and supporting osteoblast differentiation through BMP-2/RUNX2. Its paired cell and animal-model design provides a useful framework for studying bone loss driven by oxidative, inflammatory, and toxicant-related stress.
-
FGFR3 Inhibition in SLC26A2 Chondrodysplasia
2026-08-28
The reference study combines genetic deletion, inducible mouse modeling, chondrocyte assays, and pharmacological intervention to show that excessive FGFR3 signaling contributes to SLC26A2-related chondrodysplasia. Its findings support NVP-BGJ398 as a mechanistically grounded tool for testing FGFR3 pathway inhibition in rare skeletal disease, while also defining important limits for translation beyond the mouse model.
-
Indometacin and Premature Ovulation in IVF
2026-08-28
This randomized, double-blind, placebo-controlled trial evaluated whether indometacin could reduce premature ovulation during modified natural-cycle IVF. Although the overall treatment effect was not statistically significant, the findings identified a clinically relevant subgroup without an LH surge at hCG administration that may benefit from prostaglandin synthesis inhibition.
-
Sodium Phosphate Dibasic: Assay Control
2026-08-27
Sodium phosphate dibasic and Na2HPO4 are more than routine buffer ingredients: their formulation and matrix effects can shape assay interpretation. This guide connects phosphate chemistry with aquatic toxicity study design, biochemical reproducibility, and practical quality control.
-
TRPV1 and TRPA1 Drive TSLP in Nasal Epithelium
2026-08-27
The reference study identifies nasal epithelial TRPV1 and TRPA1 as functional sensors that promote TSLP production through calcium-dependent NFAT activation. Its combination of pharmacological, genetic, calcium-imaging, and localization experiments provides a mechanistic framework for studying upper-airway inflammation and related sensory ion-channel signaling.
-
Polygodial: TRPA1 Channel Activator
2026-08-26
Polygodial is a TRPA1 channel activator used to perturb sensory ion-channel signaling in research assays. Its defined chemical identity, DMSO solubility, and cold-storage requirements support controlled membrane transporter and neurophysiology workflows.
-
Tioconazole: Translational Strategy for Antifungal Research
2026-08-26
A thought-leadership guide to using Tioconazole as a mechanistic reference in antifungal drug development, with practical assay design, metabolic-stress considerations, and translational decision points informed by recent DNA-repair research.
-
SCH772984: An ERK1/2 Lens on Radioresistance
2026-08-25
A translational framework for using SCH772984 to test whether ERK1/2 activity connects angiotensin II, HIF-1α-HILPDA signaling, ferroptosis suppression, and radioresistance in nasopharyngeal carcinoma.
-
Magnetic In Vivo CAR-T Mimicry for Solid Tumors
2026-08-25
The Advanced Materials study introduces a magnetic bispecific nano-antibody that engages endogenous T cells in vivo and guides the resulting CAR-T-mimicking cells toward solid tumors. Its significance lies in combining antibody-mediated T-cell activation with external magnetic navigation, addressing two major barriers in solid-tumor immunotherapy: poor infiltration and local immunosuppression.
-
DiI (DiIC18(3)) Plasma Membrane Probe
2026-08-24
DiI (DiIC18(3)) provides orange-red fluorescence for tracking plasma membrane boundaries, lateral membrane movement, and labeled cells in live or fixed samples. It is supplied as an organic-solvent-compatible lipophilic dye, so it should not be added directly to water-based protocols or treated as a general intracellular organelle stain.
-
In Vitro Drug Response Metrics in Cancer Research
2026-08-23
Hannah R. Schwartz’s 2022 dissertation examines why relative viability and fractional viability should not be treated as interchangeable measures of anticancer activity. Its central contribution is a measurement framework that separates proliferative arrest from cell killing and emphasizes their different proportions and timing, improving interpretation of in vitro drug-response data.
-
PTEN mRNA: A Translational Route to Resistance
2026-08-22
A mechanistic and strategic guide to using EZ Cap™ Human PTEN mRNA (ψUTP) to study PTEN restoration, PI3K/Akt signaling pathway inhibition, and therapeutic resistance in translational cancer research.